The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection.


Journal

Revista da Associacao Medica Brasileira (1992)
ISSN: 1806-9282
Titre abrégé: Rev Assoc Med Bras (1992)
Pays: Brazil
ID NLM: 9308586

Informations de publication

Date de publication:
2020
Historique:
received: 05 06 2020
accepted: 12 06 2020
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 2 10 2020
Statut: epublish

Résumé

The aim of this study is to analyze the prognostic significance of ABO and Rh blood group antigens along with various parameters in patients followed-up with the diagnosis of COVID-19. We evaluated 397 patients who were follow-up and treated due to COVID-19 infections. The ages, genders, chronic diseases, ABO and Rh blood group antigens, admission rates to Intensive Care Units (ICU), and mortality rates of the patients were analyzed. The mean age of the 397 patients with COVID-19 was 47±17 years. In the blood group analysis of the patients, A Rh-positive (A +) was the most frequently seen blood type (176 patients, 44.3%) followed by O Rh-positive (0 +) (109 patients, 27,5%); 38 patients were Rh negative (Rh -) (9,6%). 53 of the patients (13,4%) were followed in ICU and 29 patients died (7,3%). Neither mortality nor admission to ICU was seen for Rh - group. The comparison of Rh groups concerning the need for ICU admission revealed a significantly high rate of ICU admission in the Rh + group (p=0,011), while no significant relationship was found between mortality and Rh antigen (p=0,069). The most frequently seen blood type among COVID-19 patients was A +. The Rh + blood group was found in all cases who were admitted to ICU and had a death outcome. The Rh + blood group was found in a significantly high number of patients who were admitted to ICU, while no significant relationship was found between mortality and Rh blood group.

Identifiants

pubmed: 32965363
pii: S0104-42302020001400086
doi: 10.1590/1806-9282.66.S2.86
pii:
doi:

Substances chimiques

Blood Group Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-90

Auteurs

Selçuk Yaylacı (S)

. Sakarya University Faculty of Medicine, Department of Internal Medicine.

Hamad Dheir (H)

. Sakarya University Faculty of Medicine, Department of Internal Medicine.

Kubilay İşsever (K)

. Sakarya University Faculty of Medicine, Department of Internal Medicine.

Ahmed Bilal Genc (AB)

. Sakarya University Faculty of Medicine, Department of Internal Medicine.

Didar Şenocak (D)

. Sakarya University Faculty of Medicine, Department of Internal Medicine.

Havva Kocayigit (H)

. Sakarya University Education and Research Hospital, Department of Intensive Care.

Ertugrul Guclu (E)

. Sakarya University Faculty of Medicine Department of Infectious Diseases.

Kezban Suner (K)

. Sakarya University Education and Research Hospital, Department of Intensive Care.

Hasan Ekerbicer (H)

. Sakarya University Faculty of Medicine Department of Public Health.

Mehmet Koroglu (M)

. Sakarya University Faculty of Medicine Department Medical Microbiology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH